Key Takeaways
- Volume-led 22% revenue growth, margin expansion underway: FY26 revenue hit ₹324.48 crores with EBITDA margin expanding 149 bps to 7.11%, driven by new packaging lines and a solar plant.
- New packaging lines are the near-term growth engine: The 3.2S and 1.6S lines commissioned in January 2026 are expected to add ₹80–85 crores annually, with margins slightly above the company average.
- PP price pass-through protects margins but adds uncertainty: All polypropylene price volatility is contractually passed to customers, yet prices have not fully normalized from war-driven spikes, creating a lingering overhang.
- Export ambitions are on hold, not abandoned: Management is waiting out tariff and geopolitical uncertainty before pursuing US distribution or new value-added export products, keeping growth domestic for now.
- What to watch next quarter: The pace of capacity utilization ramp-up on Lines 6 and 7 toward the 80–85% target, any signal on a Line 8 investment decision, and whether PP prices finally reach pre-war levels.
Revenue Growth & Capacity Expansion
- FY26 performance: Revenue grew 22.22% YoY to ₹324.48 crores, with H2 contributing ₹188.08 crores as new capacity came online. PAT grew 54.73% to ₹23.07 crores.
- New capacity dedicated to packaging: The 3.2S and 1.6S lines commissioned in January 2026 are dedicated to the packaging sector, a medium-margin category where margins run 1–1.5% below the hygiene segment. These lines are expected to contribute ₹80–85 crores annually.
- Ramp-up timeline: Management expects Lines 6 and 7 to reach 80–85% capacity utilization in approximately one to one and a half years, confirmed as roughly Q4 FY27.
- Capacity mix: Slightly above 50% of total 39,140 MTPA capacity serves the higher-margin hygiene segment. The remaining ~50% is split between medium-margin (packaging, agriculture) and lower-margin products, with agriculture carrying seasonal demand.
- Revenue mix: Hygiene contributes 50% of revenue, packaging and commercial 28–30%, and other sectors including agriculture roughly 20%. Baby diaper is the largest hygiene sub-segment, followed by adult care, femme care, and pet care.
- Next expansion decision: Management has 3–4 production line concepts under consideration but will choose based on demonstrated demand and profitability. Machine manufacturing lead time is one to one and a half years, and the company may also consider acquisitions as an alternative to new investment.
Kishan Kagathara: "I have 3-4 plans into my mind, but which one to choose, it depends on the right set of demands generated into the market and also, depends on the profitability, at what we are getting it. I would always select a good profitability and the demand when selecting a right set of line for the expansion."
Margin Structure & Profitability Levers
- FY26 profitability: EBITDA grew 39.80% to ₹55.98 crores, with margin expanding 149 bps to 7.11%. PAT grew 54.73% to ₹23.07 crores.
- PP pass-through mechanics: All polypropylene price volatility is passed directly to customers as an established industry practice, with advance notice given on price changes. The one-month spike from the war situation is normalizing but has not fully reached pre-war levels.
- Solar cost benefit: The newly commissioned 6.5 MW ground-mounted solar plant covers 50% of electricity usage, reducing power costs and contributing to the margin expansion.
- Margin profile by segment: Hygiene carries the highest margins. Packaging lines (6 and 7) run 1–1.5% below the consolidated margin. Agriculture is medium-margin with seasonality.
- FY27 margin strategy: Management plans to utilize underutilized capacity to absorb fixed costs, may outsource production using its own recipe from other manufacturers to enhance revenue and PAT margins, and will pursue expansion only after securing customer confidence on volumes.
- Receivable days increase: Receivable days rose to 78–79 days, driven by three factors: adding new customers with different SKUs requiring fixed stock, hygiene customers starting with 90-day credit terms, and higher raw material procurement to support increased production. Management characterizes this as normal.
Demand Environment & Market Position
- Market share gains: Spunweb's growth exceeding the 11% Indian market CAGR is driven by share gains from domestic competitors and import substitution, as local manufacturers with quality and reliable supply are preferred.
- Diminishing seasonality: Hygiene demand now spans roughly 11 months of the year. Agriculture retains post-monsoon to February/March seasonality. Packaging was historically festival-dependent but is now less seasonal due to year-round travel demand.
- Government tailwind: The plastic ban is boosting non-woven fabric demand for reusable bags, which are recyclable and generate lower in-house wastage than single-use plastic production.
- Customer structure: Business is recurring with no long-term supply contracts beyond quarterly POs, because product pricing depends on polypropylene. Top 5 customers represent 15% of revenue; top 10 represent 25%. Management estimated 80% of revenue comes from existing customers but did not have an exact figure ready.
- Raw material supply: Sourcing is diversified across Singapore, Saudi Arabia, and roughly 50% domestic supply. Top 5 suppliers account for 65% of purchases, with import suppliers operating on spot or block pricing and domestic suppliers (Reliance, IOCL) on one-year MOUs.
Export & Value-Added Product Strategy
- US market on hold: Spunweb previously supplied meaningful volume to the US but is waiting for tariff clarity before pursuing new product exploration or distributor relationships. When asked directly about arrangements with large US distributors, management deflected, citing uncertainty.
- Value-added products delayed: Entry into new value-added product lines is difficult currently due to the trade war and the war situation in Iran, since most value-added products are export-oriented. Management sees the current environment as too unpredictable for such investments.
- Cigate Consumers acquisition: SNL acquired a 51% stake in Cigate Consumers Private Limited, an entity dedicated to export clients for end consumer products in the B2C segment. SNL will locally source end products and supply them to export customers.
Kishan Kagathara: "We were supplying quite a good quantity to the US market, but because of the uncertainty that we were observing from the tariff and all that situation, so we currently are waiting for a good time to come for any such kind of new product exploration."
Kishan Kagathara: "Currently we are observing a trade war, we are observing a war situation in Iran, so it is very unpredicted market as of now, and most of the value-added products are able to do export in the foreign countries. So, seeing current scenario, it is a difficult time to enter into any kind of new value-added product line."
Technology & Sustainability
- Technology sourcing: All 7 production lines are sourced from China. For the spunbond category, most Indian players use Chinese lines due to lower investment cost and suitability for polypropylene granules, unlike spunlace manufacturers who may use European or German technology with different raw materials.
- Product portfolio: The company now provides 6 key fabric types: hydrophilic, hydrophobic, UV-treated, super soft, FR-treated, and anti-static fabric.
- Biodegradable readiness: Oxo-biodegradable materials exist but are not widely adopted due to cost. Even if 100% biodegradable raw material is used for diaper fabric, the 6–7 other non-biodegradable components in a diaper make the final product non-biodegradable. Government is currently prioritizing rural hygiene awareness over biodegradable mandates.
- PLA adoption gating factor: PLA and biodegradable raw material adoption requires cheaper availability. Management stated willingness to use such materials and make machinery changes if demand arises, but no timeline was committed.
Kishan Kagathara: "Unless and until PLA or biodegradable raw materials are not available into the market on a cheaper price, it is very difficult to use as of now, but ultimately, we are a B2B manufacturer. If such certain kind of demand is arising in upcoming future, then we are happy to use into our products and facility, and if required any such kind of changes into our machinery, we shall happily do so."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| New line revenue contribution | ₹80–85 crores annually from 3.2S and 1.6S lines | Annual run-rate (lines commissioned Jan 2026) |
| Capacity utilization ramp-up | Lines 6 and 7 to reach 80–85% utilization | ~Q4 FY27 (one to one and a half years) |
| Revenue growth maintenance | Maintain revenue growth at FY26 levels | Next 1–2 years |
| PAT margin improvement | Make PAT margin slightly higher than current | Next 1–2 years |
| Margin enhancement via utilization | Utilize underutilized capacity to increase margins; may outsource production using own recipe | FY27 |
| Next expansion decision trigger | Selection from 3–4 line concepts based on demand and profitability; machine lead time one to one and a half years | No pre-decided date |
Key Metrics
| Metric | FY26 |
|---|---|
| Revenue from operations (consolidated) | ₹324.48 cr, +22.22% YoY |
| H2 FY26 consolidated revenue | ₹188.08 cr |
| EBITDA (consolidated) | ₹55.98 cr, +39.80% YoY |
| EBITDA margin (consolidated) | 7.11%, expanded 149 bps YoY |
| PAT (consolidated) | ₹23.07 cr, +54.73% YoY |
| H2 FY26 consolidated PAT | ₹12.33 cr |
| Blended EBITDA margin | 17–18% (per an analyst's math, confirmed by management) |
| Hygiene revenue share | Over 50% of revenue |
| Packaging and commercial revenue share | 28–30% of revenue |
| Other sectors revenue share | ~20% of revenue |
| Revenue from existing customers | ~80% of revenue (management estimate) |
| Top 5 customer concentration | ~15% of overall revenue |
| Top 10 customer concentration | ~25% of overall revenue |
| Combined installed capacity | 39,140 MTPA across 7 production lines |
| Capacity utilization: Line 5 | 80% |
| Capacity utilization: Line 6 | 17% |
| Capacity utilization: Line 7 | 22% |
| New lines (3.2m and 1.6m Single S) expected annual revenue contribution | ₹80–85 cr |
| Solar power plant capacity | 6.5 MW ground-mounted, covering 50% of electricity units |
| Receivable days | 78–79 days |
| Indian non-woven fabric demand growth | 11% CAGR |
| Global non-woven demand forecast (FY29) | ~$40.77 bn |
| Government capital subsidy on expansion | 20% on capital investment |